Cargando…

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study

The aim of this analysis was to evaluate perceived barriers related to HCV testing, management and treatment among physicians practicing in clinics offering opioid agonist treatment (OAT). C‐SCOPE was a study consisting of a self‐administered survey among physicians practicing at clinics providing O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litwin, Alain H., Drolet, Martine, Nwankwo, Chizoba, Torrens, Martha, Kastelic, Andrej, Walcher, Stephan, Somaini, Lorenzo, Mulvihill, Emily, Ertl, Jochen, Grebely, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771477/ https://www.ncbi.nlm.nih.gov/pubmed/31074167 http://dx.doi.org/10.1111/jvh.13119

Ejemplares similares

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020)

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
por: Akiyama, Matthew J., et al.
Publicado: (2018)

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe
por: Stöver, H., et al.
Publicado: (2019)

Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
por: Kåberg, M., et al.
Publicado: (2022)

People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study
por: Conway, Anna, et al.
Publicado: (2022)

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
por: Conway, Anna, et al.
Publicado: (2023)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
por: Aldabergenov, D, et al.
Publicado: (2022)

Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)

Opioid and Antibiotic Prescribing
por: Nalliah, Romesh P., et al.
Publicado: (2020)

Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
por: Nixon, Lara L., et al.
Publicado: (2019)

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
por: Moallef, Soroush, et al.
Publicado: (2022)

The Role of Pharmacogenomics in Opioid Prescribing
por: Wong, Aaron K., et al.
Publicado: (2022)

The Association of Prescriber Awareness of Opioid Consumption Trends with Postoperative Opioid Prescription Volume in Hip Arthroscopy: Prescriber Awareness of Opioid Consumption
por: Cunningham, Daniel J., et al.
Publicado: (2020)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit
por: Chua, Kao-Ping, et al.
Publicado: (2023)

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

Association of State Opioid Duration Limits With Postoperative Opioid Prescribing
por: Agarwal, Sunil, et al.
Publicado: (2019)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention’s Opioid Prescribing Guidelines
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar
por: Nyein, Phyo Pyae, et al.
Publicado: (2023)

Opioid prescribing patterns within otolaryngology
por: Murphey, Alexander W., et al.
Publicado: (2019)

Secular trends in opioid prescribing in the USA
por: Pezalla, Edmund J, et al.
Publicado: (2017)

Prescribing opioids and psychotropic drugs in pregnancy
por: Patrick, Stephen W, et al.
Publicado: (2017)

Opioid prescribing in dentistry – is there a problem?
por: Teoh, Leanne
Publicado: (2020)

Addressing (over)prescribing of opioids in surgery
por: Schäfer, Willemijn L.A., et al.
Publicado: (2020)

Risk factors for fatal outcome in patients with opioid dependence treated with methadone in a family medicine setting in Croatia
por: Cerovečki, Venija, et al.
Publicado: (2013)

P232 MOLECULAR PHYLOGENETICS OF HEPATITIS C VIRUS (HCV) AS A TOOL TO UNDERSTAND THE HCV EPIDEMIC IN BRITISH COLUMBIA (BC), CANADA
por: Olmstead, A., et al.
Publicado: (2014)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain
por: Goldstick, Jason E., et al.
Publicado: (2021)

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies
por: Grebely, Jason, et al.
Publicado: (2018)

Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline
por: Encinosa, William, et al.
Publicado: (2021)

Opioid Substitution: More than Only Methadone!
por: Torrens, M.
Publicado: (2022)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

Opioid Prescribing Habits for Common Arthroscopic Procedures in Opioid Naïve Patients
por: Thompson, Matthew M., et al.
Publicado: (2021)

Statewide cross-sectional survey of emergency departments’ adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practices
por: Penm, Jonathan, et al.
Publicado: (2018)

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk
por: Vecchio, Sarah, et al.
Publicado: (2020)

Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids
por: Chua, Kao-Ping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kndv8ko8u9f7l2mqb528emoool